Which institute has recently partnered with CEPI to enhance global res...
The Serum Institute of India (SII) has partnered with CEPI, with an investment of up to $30 million to expand manufacturing capacity. This collaboration aims to enable swift production and equitable distribution of investigational vaccines during epidemics and pandemics, aligning with the ambitious 100 Days Mission for developing vaccines against infectious diseases.
View all questions of this test
Which institute has recently partnered with CEPI to enhance global res...
Serum Institute Partners with CEPI:
The Serum Institute of India, the world's largest vaccine manufacturer by number of doses produced, has recently partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to enhance global responses to disease outbreaks. CEPI is an international organization that aims to accelerate the development of vaccines against emerging infectious diseases. This partnership will enable the Serum Institute to collaborate with CEPI on research and development projects to address global health challenges.
$30 Million Investment:
As part of this partnership, the Serum Institute has received a $30 million investment from CEPI to expand its manufacturing capacity. This investment will allow the Serum Institute to scale up its production capabilities and develop new vaccines to combat emerging infectious diseases. The goal is to ensure that the world is better prepared to respond to future pandemics and outbreaks.
Significance of the Partnership:
The partnership between the Serum Institute and CEPI is significant because it brings together the expertise and resources of both organizations to advance global health security. By working together, they can leverage their strengths in vaccine development and manufacturing to accelerate the response to disease outbreaks. This collaboration will help to ensure that vaccines are more readily available during public health emergencies, ultimately saving lives and protecting communities worldwide.